PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway (original) (raw)

• Pineda Torra, I., Gervois, P. & Staels, B. Peroxisome proliferator-activated receptor α in metabolic disease, inflammation, atherosclerosis and aging. Curr. Opin. Lipidol. 10, 151–159 (1999).
  Article CAS Google Scholar
• Brun, R.P. et al. Differential activation of adipogenesis by multiple PPAR- isoforms. Genes Dev. 10, 974–984 (1996).
  Article CAS Google Scholar
• Jiang, C., Ting, A.T. & Seed, B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82–86 (1998).
  Article CAS Google Scholar
• Ricote, M., Li, A.C., Willsson, T.M., Kelly, C.J. & Glass, C.K. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391, 79–82 (1998).
  Article CAS Google Scholar
• Chinetti, G. et al. Activation of peroxisome proliferator-activated receptorsγ and γ induces apoptosis of human monocyte-derived macrophages. J. Biol. Chem. 273, 25573–25580 (1998).
  Article CAS Google Scholar
• Tontonoz, P., Nagy, L., Alvarez, J., Thomazy, V. & Evans, R. PPAR-γ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241–252 (1998).
  Article CAS Google Scholar
• Chinetti, G. et al. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 101, 2411–2417 (2000).
  Article CAS Google Scholar
• Brooks-Wilson, A. et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nature Genet. 22, 336–345 (1999).
  Article CAS Google Scholar
• Lawn, R.M. et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. 104, R25–R31 (1999).
  Article CAS Google Scholar
• Bodzioch, M. et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nature Genet. 22, 347–351 (1999).
  Article CAS Google Scholar
• Rust, S. et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nature Genet. 22, 352–355 (1999).
  Article CAS Google Scholar
• Hobbs, H.H. & Rader, D.J. ABC1: connecting yellow tonsils, neuropathy, and very low HDL. J. Clin. Invest. 104, 1015–1007 (1999).
  Article CAS Google Scholar
• Wolffenbuttel, B.H., Gomis, R., Squatrito, S., Jones, N.P. & Patwardhan, R.M. Addition of low-dose rosiglitazone to sulphonylurea therapy glycaemic control in Type 2 diabetic patients. Diabet. Med. 17, 40–47 (2000).
  Article CAS Google Scholar
• Vu-Dac, N. et al. The nuclear receptor peroxisome proliferator-activated Receptors α and Rev-erb γ mediate the species-specific regulation of apolipoprotein A-I expression by fibrates. J. Biol. Chem. 273, 25713–25720 (1998).
  Article CAS Google Scholar
• Janowski, B.A., Willy, P.J., Devi, T.R., Falck, J.R. & Mangelsdorf, D.J. An oxysterol signalling pathway mediated by the nuclear receptor LXR-α. Nature 383, 728–731 (1996).
  Article CAS Google Scholar
• Costet, P., Luo, Y., Wang, N. & Tall, A.R. Sterol-dependent transactivation of the human ABC1 promoter by LXR-/RXR. J. Biol. Chem. 275, 28240–28245 (2000).
  CAS PubMed Google Scholar
• Frick, M.H. et al. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Circulation 96, 2137–2143 (1997).
  Article CAS Google Scholar
• Ericsson, C. et al. Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet 347, 849–53 (1996).
  Article CAS Google Scholar
• Law, R. et al. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J. Clin. Invest. 98, 1897–1905 (1996).
  Article CAS Google Scholar
• Rubins, H.B. et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N. Engl. J. Med. 341, 410–418 (1999).
  Article CAS Google Scholar
• Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801–809 (1993).
  Article CAS Google Scholar
• Willson, T.M., Brown, P.J., Sternbach, D.D. & Henke, B.R. The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 43, 527–550 (2000).
  Article CAS Google Scholar
• Forman, B.M., Ruan, B., Chen, J., Schroepfer, G.J. Jr. & Evans, R.M. The orphan nuclear receptor LXR-α is positively and negatively regulated by distinct products of mevalonate metabolism. Proc. Natl. Acad. Sci. USA 94, 10588–10593 (1997).
  Article CAS Google Scholar
• Venkateswaran, A. et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR-α. Proc. Natl. Acad. Sci. USA 97, 12097–12102 (2000).
  Article CAS Google Scholar
• Forte, T.M. & McCall, M.R. The role of apolipoprotein A-I-containing lipoproteins in atherosclerosis. Curr. Opin. Lipidol. 5, 354–364 (1994).
  Article CAS Google Scholar
• Becq, F. et al. ABC1, an ATP binding cassette transporter required for phagocytosis of apoptotic cells, generates a regulated anion flux after expression in Xenopus laevis oocytes. J. Biol. Chem. 272, 2695–2699 (1997).
  Article CAS Google Scholar
• Hamon, Y. et al. Interleukin-1β secretion is impaired by inhibitors of the ATP binding cassette transporter, ABC1. Blood 90, 2911–2915 (1997).
  CAS PubMed Google Scholar
• Remaley, A.T. et al. Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. Proc. Natl. Acad. Sci. USA 96, 12685–12690 (1999).
  Article CAS Google Scholar
• Marx, N., Sukhova, G., Murphy, C., Libby, P. & Plutzky, J. Macrophages in human atheroma contain PPAR-γ: differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPAR-γ) expression and reduction of MMP-9 activity through PPAR-gamma activation in mononuclear phagocytes in vitro. Am. J. Pathol. 153, 17–23 (1998).
  Article CAS Google Scholar
• Tobin, K.A. et al. Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-α. Mol. Endocrinol. 14, 741–752 (2000).
  CAS PubMed Google Scholar
• Ji, Y. et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272, 20982–20985 (1997).
  Article CAS Google Scholar
• Barman Balfour, J.A. & Plosker, G.L. Rosiglitazone. Drugs 57, 921–930 (1999).
  Article Google Scholar
• Staels, B. et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98, 2088–2093 (1998).
  Article CAS Google Scholar
• Vu-Dac, N. et al. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J. Clin. Invest. 96, 741–750 (1995).
  Article CAS Google Scholar
• Delerive, P. et al. Oxidized phospholipids activate PPAR-α in a phospholipase A2-dependant manner. FEBS Lett. 471, 34–38 (2000).
  Article CAS Google Scholar
• Basu, S.K., Goldstein, J.L., Anderson, G.W. & Brown, M.S. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc. Natl. Acad. Sci. USA 73, 3178–3182 (1976).
  Article CAS Google Scholar
• Kritharides, L., Christian, A., Stoudt, G., Morel, D. & Rothblat, G.H. Cholesterol metabolism and efflux in human THP-1 macrophages. Arterioscler. Throm. Vasc. Biol. 18, 1589–1599 (1998).
  Article CAS Google Scholar
• Folch, J., Lees, M. & Sloane Stanley, G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226, 497–5 (1957).
  CAS PubMed Google Scholar